Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.39 -0.05 (-3.47%)
As of: Nov 11, 2026 · 11:03 AM EST

Cadrenal Therapeutics (CVKD) Notes Payables (2022)

Updated

Cadrenal Therapeutics (CVKD) posted Notes Payables of $43,728 for Q4 2022.

Analysis

Cadrenal Therapeutics (CVKD) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cadrenal Therapeutics 557,746.58 -12.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 43,728.00
API Access

Cadrenal Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CVKD&period=max&api_key=YOUR_API_KEY